Francesco Salpietro


Francesco Salpietro


Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104-2808
+1 215 994 2934 | +1 215 994 2222

| vCard | PDF

Practice Areas

Francesco Salpietro focuses his practice on corporate and securities matters. Mr. Salpietro represents publicly registered companies across a wide range of matters, including advice on federal securities laws reporting obligations, debt and equity securities offerings, mergers and acquisitions and general corporate governance matters. In addition, Mr. Salpietro advises privately-held corporations, private equity sponsors and their portfolio companies on mergers and acquisitions and general corporate matters. 

Mr. Salpietro maintains an active pro bono practice, including representation of LGBT and other individuals in state court and federal immigration proceedings. He was a Dechert summer associate in 2015.

  • Select Medical Corporation (NYSE:SEM), one of the nation’s largest providers of specialized hospital, rehabilitative and outpatient care, in the US$753 million acquisition of U.S. HealthWorks, Inc. by its Concentra operating segment, as well as advice on corporate governance matters and federal securities laws reporting obligations. 
  • FS Energy and Power Fund, a publicly registered, non-traded business development company, in its Rule 144A/Reg S offering of US$500 million of 7.50% senior secured notes.
  • WhiteHorse Finance, Inc. (NASDAQ:WHF), a business development company advised by an affiliate of H.I.G. Capital, L.L.C., in connection with capital markets transactions and general corporate matters.
  • Aviragen Therapeutics, Inc. (formerly NASDAQ:AVIR), a biopharmaceutical company focused on the discovery and development of products to prevent and treat infectious diseases, in its merger with Vaxart, Inc. (NASDAQ:VXRT) and related federal securities laws reporting obligations.
  • Iconix Brand Group, Inc. (NASDAQ:ICON), in the US$125 million exchange of its 1.50% convertible senior subordinated notes for its 5.75% convertible senior subordinated second lien notes, as well as related amendments to its US$300 million senior secured loan credit facility with Deutsche Bank AG.
  • Griffon Corporation (NYSE:GFF), a diversified holding company, in the preparation and filing of its shelf registration statements.
  • Integrated Oncology Network, LLC (ION), a physician management, radiation oncology management and cancer center development company, in connection with its agreement to partner with private equity investment firm Silver Oak Services Partners, LLC to recapitalize ION.
  • Travel Leaders Group, a travel management company managing leisure, business and franchise travel operations under a variety of diversified divisions and brands, in several acquisition transactions and related financing activities.
  • Children’s Dental Group, a specialized pediatric dental and orthodontic provider based in La Palma, California, in the acquisition of eight of its offices by Western Dental, a portfolio company of New Mountain Capital.
  • Court Square Capital Partners in its sale of all outstanding shares of Letco Medical LLC (Letco) to Letco’s current management team.
  • University of Michigan, B.M.A., 2013, highest honors, James B. Angell Scholar
  • University of Pittsburgh School of Law, J.D., 2016, magna cum laude; Order of the Coif; Lead Executive Editor of the University of Pittsburgh Law Review; Benjamin H. Teplitz Award; David R. Bookstaver Award; Faculty Award for Excellence in Legal Scholarship; Law School Trial Advocacy Award; Pro Bono Service Leadership Recognition Award; School of Law Community Service Award
  • Pennsylvania
  • National LGBT Bar Association
  • University of Pittsburgh School of Law, Alumni Association